Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMortgage Advice Bureau Regulatory News (MAB1)

Share Price Information for Mortgage Advice Bureau (MAB1)

Share Price is delayed by 15 minutes
Get Live Data
525.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 4.00 (0.765%)
Market Cap: £302.10m
MAB1 Live PriceLast checked at - London Stock Exchange

Intraday Mortgage Advice Bureau Share Chart

Trading Update

22 Jan 2019 07:00

RNS Number : 6986N
Mortgage Advice Bureau(Holdings)PLC
22 January 2019
 

22 January 2019

Mortgage Advice Bureau (Holdings) plc ("MAB" or the "Group")

Trading Update 

Mortgage Advice Bureau (Holdings) plc (AIM:MAB1), one of the UK's leading consumer intermediary brands and specialist Appointed Representative Networks, today issues a trading update for the year ended 31 December 2018, ahead of publishing its final results announcement on Tuesday, 19 March 2019(1).

Revenue for the year ended 31 December 2018 increased by 13% to £123m driven by a 12% increase in the average number of Advisers to 1,130 in the year ended 31 December 2018 (2017: 1,008). The total number of Advisers had increased to 1,213 at 31 December 2018, an increase of 135 or 13% since last year end (2017: 1,078). For 2018 as a whole, we saw an increase in average revenue per adviser of 1%, continuing our growth in productivity despite the ongoing economic uncertainty driven by the Brexit agenda and a reduction in housing transactions overall.

The Group's profit before tax for the year ended 31 December 2018 is broadly in line with the Board's expectations. At 31 December 2018, the Group had a strong balance sheet with a cash position of over £25m, including over £13m of unrestricted cash balances. 

Although UK Finance has not recently updated its estimates for gross new mortgage lending for 2018 and 2019, the current information and run rates broadly support their previous estimates of £260bn and £271bn for 2018 and 2019 respectively, indicating that the market is likely to be relatively flat in the near term. These figures exclude Product Transfers, and it has only been over the last year or so that the large lenders have engaged intermediaries to help them to retain their existing mortgage borrowers through product transfers, with intermediaries continuing to grow their share of this market. UK Finance has recently revised its original estimates for the size of the product transfer market, indicating an annual market size of c. £140bn.

(1) It is expected that a proposed final dividend in respect of the year ended 31 December 2018 will be paid on 24 May 2019 to shareholders on the register at close of business on 26 April 2019.

Peter Brodnicki, CEO of Mortgage Advice Bureau (Holdings) plc, said:

"MAB has delivered another strong performance despite the uncertainty caused by the ongoing Brexit negotiations. We continue to grow our market share and invest in accordance with our very clear strategy to ensure continued and sustainable growth.

 "We are looking forward to capitalising upon our recent protection initiatives to increase performance whilst also delivering the initial phase of our next generation MIDAS technology in the first half of this year. Both of these initiatives are already proving to be important recruitment drivers for Appointed Representatives, advisers and lead sources. This initial phase and further releases across 2019 and 2020 will benefit MAB advisers and customers, through improvements in efficiency, productivity, lead generation, product offering and customer experience. We are excited about how delivering this will help us to attract more advisers and customers into MAB, assisting our future growth plans."

 

Market Abuse Regulation (MAR) Disclosure

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

Enquiries:

Mortgage Advice Bureau (Holdings) plc +44 (0)1332 525007

Peter Brodnicki, Chief Executive Officer

Ben Thompson, Managing Director

David Preece, Chief Operating Officer

Lucy Tilley, Finance Director

Nominated Adviser and Broker: +44 (0)20 7260 1000

Numis Securities Limited

Stephen Westgate / Jamie Lillywhite (Corporate Finance)

Michael Burke (Corporate Broking)

 

Media Enquiries:

 

investorrelations@mab.org.uk

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTSEEESFFUSELF
Date   Source Headline
1st Dec 20255:25 pmRNSDirectors' Shareholdings and PDMR notification
18th Nov 20252:11 pmRNSDirectors' Shareholdings and PDMR notification
14th Nov 20257:00 amRNSNotice of Capital Markets Day Update
7th Nov 20255:15 pmRNSHolding(s) in Company
4th Nov 20251:34 pmRNSDirector/PDMR Shareholding
16th Oct 202512:40 pmRNSDirector/PDMR Shareholding
16th Oct 202512:38 pmRNSGrant of Options, PDMR Dealing,Total Voting Rights
30th Sep 20254:43 pmRNSDirector/PDMR Shareholding
25th Sep 20254:30 pmRNSDirector/PDMR Shareholding
23rd Sep 20255:01 pmRNSBlock listing Interim Review
23rd Sep 20257:00 amRNSInterim Results
17th Sep 20252:30 pmRNSDirector/PDMR Shareholding
2nd Sep 20257:00 amRNS-RNotice of HY25 Results and Investor Presentation
29th Aug 20251:13 pmRNSDirector/PDMR Shareholding
27th Aug 20254:26 pmRNSHolding(s) in Company
21st Aug 20253:01 pmRNSDirector/PDMR Shareholding
31st Jul 202511:32 amRNSDirector/PDMR Shareholding
24th Jul 20257:00 amRNSTrading Update
22nd Jul 20255:59 pmRNSEBT Share Purchase
17th Jul 20259:46 amRNSDirector/PDMR Shareholding
16th Jul 20251:58 pmRNSHolding(s) in Company
9th Jul 20259:05 amRNS-RMAB Launches First-Time Buyer Campaign
3rd Jul 20259:54 amRNSDirector/PDMR Shareholding
27th Jun 20253:46 pmRNSNotification of major holdings
19th Jun 20257:00 amRNSBoard Changes
18th Jun 202510:55 amRNSDirector/PDMR Shareholding
11th Jun 202510:18 amRNSHolding(s) in Company
3rd Jun 20252:47 pmRNSDirector/PDMR Shareholding
30th May 20253:52 pmRNSDirector/PDMR Shareholding
22nd May 20257:00 amRNSResults of Annual General Meeting
21st May 20257:00 amRNSAGM Trading Statement
16th May 202512:30 pmRNSDirector/PDMR Shareholding
6th May 202512:37 pmRNSHolding(s) in Company
1st May 20255:19 pmRNSDirectors' Shareholdings and PDMR notification
30th Apr 20255:15 pmRNSGrant of Options, PDMR Dealing and TVR
29th Apr 20258:48 amRNSNotice of AGM
17th Apr 20251:40 pmRNSHolding(s) in Company
16th Apr 20259:58 amRNSDirector/PDMR Shareholding
10th Apr 20257:00 amRNSAppointment of Joint Corporate Broker
4th Apr 20257:10 amRNSAnnual Report and Notice of AGM
1st Apr 20253:51 pmRNSDirector/PDMR Shareholding
27th Mar 20259:18 amRNSHolding(s) in Company
19th Mar 20257:00 amRNSDirectorate Change
18th Mar 20257:00 amRNSFinal Results for the year ended 31 December 2024
17th Mar 20253:40 pmRNSDirector/PDMR Shareholding
14th Mar 20257:00 amRNSBlock Admission Application
5th Mar 202511:29 amRNSDirector/PDMR Shareholding
26th Feb 20257:00 amRNS-RNotice of Investor Presentation
18th Feb 20253:57 pmRNSDirector/PDMR Shareholding
17th Feb 20253:29 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.